DERMIRA, INC.

Profile

Company Names

DERMIRA, INC.

Addresses

275 MIDDLEFIELD ROAD, SUITE 150, MENLO PARK, CA 94025

2055 WOODSIDE ROAD, SUITE 270, REDWOOD CITY, CA 94061

Phone Numbers

650 421 7200

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$113,006,729.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2018-12-17 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
5
2017-12-04 
$500,000.00 
$500,000.00 
$0.00 
Equity 
4
2016-08-29 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
3
2014-08-15 
$50,999,991.00 
$50,999,996.00 
$5.00 
Equity 
2
2013-03-28 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
1
2011-08-04 
$34,006,738.00 
$42,006,739.00 
$8,000,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EUGENE 
 
BAUER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
AVC ROYALTY FUND I, LLC   |  DR. TATTOFF, INC.   |  VYTERIS, INC.   |  CERECOR INC.   |  KADMON HOLDINGS, LLC   |  DERMIRA, INC.   |  EVOMMUNE, INC.
EUGENE 
A. 
BAUER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MEDISYNC BIOSERVICES INC   |  DR. TATTOFF, INC.   |  CERECOR INC.   |  DERMIRA, INC.   |  APPLIED UV, INC.
DAVID 
E. 
COHEN 
DIRECTOR
MIDWOOD CAPITAL PARTNERS LP   |  MIDWOOD CAPITAL PARTNERS QP LP   |  BRICKELL BIOTECH, INC.   |  DERMIRA, INC.   |  TIMBER PHARMACEUTICALS, INC.
FRED 
 
CRAVES 
DIRECTOR
DERMIRA, INC.   |  TWIST BIOSCIENCE CORP   |  MADRIGAL PHARMACEUTICALS, INC.
FRED 
B. 
CRAVES 
DIRECTOR
DERMIRA, INC.   |  MADRIGAL PHARMACEUTICALS, INC.
MATTHEW 
 
FUST 
DIRECTOR
DERMIRA, INC.   |  ARSENAL BIOSCIENCES, INC.   |  NEUMORA THERAPEUTICS, INC.   |  CRINETICS PHARMACEUTICALS, INC.   |  STAR THERAPEUTICS LLC   |  ELECTRA THERAPEUTICS, INC.
MATTHEW 
K. 
FUST 
DIRECTOR
SUNESIS PHARMACEUTICALS INC   |  DERMIRA, INC.   |  CRINETICS PHARMACEUTICALS, INC.
CHRISTOPHER 
 
GRIFFITH 
EXECUTIVE OFFICER
DERMIRA, INC.   |  PROVINCIAL GARDENS 3120 LLC
CHRISTOPHER 
M. 
GRIFFITH 
EXECUTIVE OFFICER, PROMOTER
DERMIRA, INC.
ANDREW 
 
GUGGENHIME 
EXECUTIVE OFFICER
CALISTOGA PHARMACEUTICALS INC   |  DERMIRA, INC.
ANDREW 
L. 
GUGGENHIME 
EXECUTIVE OFFICER
CARDIODX INC   |  DERMIRA, INC.
CHRISTOPHER 
 
HORAN 
EXECUTIVE OFFICER
DERMIRA, INC.   |  AMERICAN INFRASTRUCTURE GROUP, INC.
WENDE 
 
HUTTON 
DIRECTOR
TRANSCEND MEDICAL INC   |  APIERON INC   |  CALIBRA MEDICAL, INC.   |  THERACLONE SCIENCES, INC.   |  REVISION OPTICS INC   |  ALTHEOS, INC.   |  ALDEA PHARMACEUTICALS, INC.   |  MATURE WOMEN-S HEALTH SOLUTIONS, INC.   |  DERMIRA, INC.   |  LABRYS BIOLOGICS, INC.   |  BUTTERFLY HEALTH, INC.   |  CHRONO THERAPEUTICS INC.   |  MINIMALLY INVASIVE DEVICES INC.   |  HERA THERAPEUTICS INC.   |  ONCORESPONSE INC   |  HYALEX ORTHOPAEDICS, INC.   |  QLARIS BIO, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  GLOOKO, INC.   |  ALCHERA INC   |  ANTIVA BIOSCIENCES, INC.   |  ONCORESPONSE, INC
WENDE 
S. 
HUTTON 
DIRECTOR
DERMIRA, INC.   |  ANTIVA BIOSCIENCES, INC.
LORI 
 
LYONS-WILLIAMS 
EXECUTIVE OFFICER
DERMIRA, INC.   |  RAPT THERAPEUTICS, INC.
MARK 
 
MCDADE 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  DERMIRA, INC.   |  PLATELET BIOGENESIS, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  TALARIS THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.   |  BOULDER CARE, INC.   |  SODA HEALTH, INC.   |  DUALITAS THERAPEUTICS, INC.
MARK 
D. 
MCDADE 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  DERMIRA, INC.   |  AIMMUNE THERAPEUTICS, INC.
JAKE 
 
NUNN 
DIRECTOR
HYPERION THERAPEUTICS INC   |  TV2 HOLDING CO   |  ACIEX THERAPEUTICS, INC.   |  DERMIRA, INC.   |  TRIVASCULAR TECHNOLOGIES, INC.   |  ADDEX THERAPEUTICS LTD.   |  ZENAS BIOPHARMA, INC.
JAKE 
R. 
NUNN 
DIRECTOR
HYPERION THERAPEUTICS INC   |  DERMIRA, INC.   |  TRIVASCULAR TECHNOLOGIES, INC.   |  REGULUS THERAPEUTICS INC.
JASON 
RALEIGH 
NUNN 
DIRECTOR
DERMIRA, INC.
LUIS 
 
PENA 
EXECUTIVE OFFICER
DERMIRA, INC.   |  EVOMMUNE, INC.
LUIS 
C. 
PENA 
EXECUTIVE OFFICER, PROMOTER
DERMIRA, INC.
WILLIAM 
R. 
RINGO 
DIRECTOR
DERMIRA, INC.
KATHLEEN 
 
SEBELIUS 
DIRECTOR
DERMIRA, INC.   |  DEVOTED HEALTH, INC.   |  HUMACYTE, INC.   |  GRAND ROUNDS, INC.
THOMAS 
 
WIGGANS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
VICTORY PHARMA INC   |  CORTHERA INC   |  DERMIRA, INC.   |  ANNEXON, INC.
THOMAS 
G. 
WIGGANS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
SOMAXON PHARMACEUTICALS, INC.   |  DERMIRA, INC.   |  ANNEXON, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-12-31
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-12-17 
2017-12-18
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-12-04 
2016-09-12
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-08-29 
2014-09-30
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-08-15 
2013-06-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2012-09-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011